Search

everythinglearnresearchcommunity

for

Search:↓

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

A girl with rickets and hair loss was found to have a rare condition where her body didn't respond to vitamin D treatment.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Shift nurses show altered body temperature and stress hormone levels, suggesting their body clocks adjust to irregular schedules.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Minoxidil effectively treats female pattern hair loss.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Minoxidil effectively treats hair loss, with better results in women.